Literature DB >> 28958679

Finding the right combination antiviral therapy for influenza.

Michael G Ison1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28958679     DOI： 10.1016/S1473-3099(17)30537-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection.

Authors:  Keita Fukao; Takeshi Noshi; Atsuko Yamamoto; Mitsutaka Kitano; Yoshinori Ando; Takahiro Noda; Kaoru Baba; Kazumi Matsumoto; Naoko Higuchi; Minoru Ikeda; Takao Shishido; Akira Naito
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

2.  Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections.

Authors:  Valentijn Vergote; Lies Laenen; Raf Mols; Patrick Augustijns; Marc Van Ranst; Piet Maes
Journal:  Front Cell Infect Microbiol       Date:  2021-03-15       Impact factor: 5.293

Review 3.  Advances in Development and Application of Influenza Vaccines.

Authors:  Jidang Chen; Jiehuang Wang; Jipei Zhang; Hinh Ly
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.